GlaxoSmithKline Reduces Prices Of Liquid Glucose Beverage In China By 50 Percent
This article was originally published in PharmAsia News
Executive Summary
British pharmaceutical giant GlaxoSmithKline put a focus on the consumer products market in China when it made the unexpected announcement that it would reduce the price of its liquid glucose drink Lucozade in China by 50 percent